GlassScriptPhysician profile
Michael Sean Stephens
NPI 1861435869
$2,070.84
in general payments reported to CMS, 2019-2025
7 companies · $24.11 in 2025
The $24.11 reported for 2025 was less than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $454 · 2022: $485 · 2023: $1,094 · 2024: $13.75 · 2025: $24.11.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $528 · Travel and Lodging: $338 · Food and Beverage: $266.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $528.46 |
| Travel and Lodging | $337.82 |
| Food and Beverage | $265.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $944.45 | 2021-2023 | Senza |
| Collegium Pharmaceutical, INC. | $575.47 | 2021-2023 | Belbuca, Xtampza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $376.54 | 2021-2025 | Relistor |
| Biodelivery Sciences International, INC. | $115.19 | 2021 | |
| Depuy Synthes Sales INC. | $26.98 | 2023-2024 | Orthovisc |
| Ibsa Pharma INC. | $19.75 | 2023 | Tirosint, Licart |
| Redhill Biopharma INC. | $12.46 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Stephens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.